is imcivree a glp-1 IMCIVREE™ (setmelanotide) – The First FDA-Approved Therapy for Specific Rare Genetic Diseases of Obesity Clinical Review - Setmelanotide (Imcivree)
Pay in 4 interest-free payments of $6.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3




























